Login / Signup

Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer.

Pranav MurthyMazen S ZenatiAmr I Al AbbasCaroline J RieserNathan BaharyMichael T LotzeHerbert J ZehAmer H ZureikatBrian A Boone
Published in: Annals of surgical oncology (2019)
Post-treatment SII may be a useful prognostic marker in PDAC patients receiving NAT.
Keyphrases
  • lymph node
  • oxidative stress
  • rectal cancer
  • locally advanced
  • radiation therapy
  • replacement therapy
  • drug induced